Because both MuRF1 (8, 9, 10) and atrogin-1 (32, 33) have been implicated in promoting cardiac muscle atrophy or inhibiting cardiac hypertrophy, we also analyzed the protein levels of MuRF1 and atrogin-1 in cardiomyocytes. Here, FBXO32 is linked to cardiac hypertrophy.